Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Washington Drug Letter > Deadline Set for Generic-Drug Makers to Withdraw Pending ANDAs or Pay Fee

Washington Drug Letter

Aug. 27, 2012 | Vol. 44 No. 34

Deadline Set for Generic-Drug Makers to Withdraw Pending ANDAs or Pay Fee

Generic drugmakers have until Sept. 28 to either withdraw pending ANDAs or face a backlog fee, the FDA says.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Drug Industry Seeks Clarity on FDA Biosimilar User Fees House Lawmakers Promise to Pursue Shielding User Fees From Sequestration House Lawmakers Promise to Pursue Shielding User Fees from Sequestration Drug Industry Seeks Clarity on FDA Biosimilar User Fees

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.